Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Neurology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Cenobamate Impact on Cognition in Tuberous Sclerosis Complex
February 2026
In adults with tuberous sclerosis complex, add-on cenobamate improved executive function, quality of life, and stress.
Read more
9 Apr 2025
Landmark Migraine Study Identifies 778 Genetic Risk Variants in Veterans: AAN 2025
A genome-wide association study (GWAS) presented at the 2025 American Academy of Neurology (AAN) Annual Meeting in San Diego has identified 778 previously unknown genetic variants associated with migraine, shedding new light on the condition’s genetic underpinnings across racial and ethnic groups.
8 Apr 2025
Inspire Study Links Spinal Stimulation to Recovery in Diabetic Neuropathy: AAN 2025
At the 2025 American Academy of Neurology (AAN) Annual Meeting in San Diego, researchers presented late-breaking data from the Inspire Study, a trial exploring spinal cord stimulation (SCS) as a holistic treatment for painful diabetic peripheral neuropathy (pDPN).
8 Apr 2025
Parkinson’s Symptoms Improved in TEMPO-2 Trial: AAN 2025
New results from the Phase III TEMPO-2 trial, presented at the 2025 American Academy of Neurology (AAN) Annual Meeting in San Diego, indicate that flexible-dose tavapadon significantly improved motor symptoms and daily functioning in adults with early Parkinson’s disease (PD), compared with placebo.
8 Apr 2025
Lorazepam Treatment Enhanced by Phenobarbital in Alcohol Withdrawal Syndrome Outcomes
In hospitalized patients with alcohol withdrawal syndrome (AWS), early addition of phenobarbital to lorazepam-based treatment significantly reduces the length of stay and the need for mechanical ventilation compared to dexmedetomidine, according to a new retrospective study conducted in a U.S. tertiary hospital.
6 Apr 2025
New Stroke Risk Trend Emerges in Younger Adults: AAN 2025
At the 2025 American Academy of Neurology (AAN) Annual Meeting, researchers presented compelling new data showing a sharp increase in hospitalizations for cervical artery dissection, a potentially life-threatening cause of stroke, particularly in adults under 50.
6 Apr 2025
Luteal Phase Heightens Avoidance Responses
The menstrual cycle significantly impacts women’s emotional decision-making and cognitive processing, according to a new EEG study examining approach-avoidance behaviors across different hormonal phases.
3 Apr 2025
Moderate Alcohol Consumption Linked to Alzheimer's Biomarkers in New Study
Light-to-moderate alcohol consumption may contribute to increased amyloid beta (Aβ) deposition, a hallmark biomarker of Alzheimer’s disease, according to new findings from the ALBION study.
1 Apr 2025
Language Recovery Possibilities in Chronic Stroke Aphasia
A chronic stroke aphasia study has revealed that significant language recovery can occur even after the initial recovery phase, providing hope for patients who might otherwise feel that recovery is no longer possible.
Loading posts...
« Previous
1
…
21
22
23
24
25
…
37
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View